Dr. Reddy's Laboratories Stock Analysis

Dr. Reddy's Laboratories Limited is a leading pharmaceutical company operating globally. It manufactures and markets a wide range of pharmaceutical products and active ingredients. Let's dive into a detailed analysis of the company's stock.

Overview

The company operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segments. It is headquartered in Hyderabad, India and has a significant presence in the healthcare sector.

Key Financial Statistics

• Current Price: INR 6218.75
• Market Cap: INR 1,03,56,70,65,088
• Dividend Yield: 0.67%
• Trailing P/E: 19.87
• Forward P/E: 18.60

Company Officers

The company is led by a team of experienced and accomplished individuals including the Co-Chairman, MD, CEO, CFO, and other key executives.

Key Ratios and Margins

• Profit Margins: 19.24%
• Return on Assets: 12.37%
• Debt to Equity: 7.41
• Operating Margins: 24.74%

Analyst Recommendations

With a target mean price of INR 5909.41 and a recommendation mean of 2.9 (Hold), the stock has been rated by 37 analysts.

Conclusion

Dr. Reddy's Laboratories stock presents a strong financial position, experienced leadership, and positive analyst recommendations. It is essential to monitor the company's performance and market dynamics for informed investment decisions.